Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma

Biomaterials. 2014 Feb;35(7):2322-35. doi: 10.1016/j.biomaterials.2013.11.039. Epub 2013 Dec 12.

Abstract

The combined treatment of chemotherapeutant and microRNA (miR) has been proven to be a viable strategy for enhancing chemosensitivity due to its synergistic effect for tumor therapy. However, the co-delivery of drugs and genes remains a major challenge as they lack efficient co-delivery carriers. In this study, three amphiphilic star-branched copolymers comprising polylactic acid (PLA) and polydimethylaminoethyl methacrylate (PDMAEMA) with AB3, (AB3)2,and (AB3)3 molecular architectures were synthesized respectively by a combination of ring-opening polymerization, atom transfer radical polymerization, and click chemistry via an "arm-first" approach. The star copolymers possessed a low critical micelle concentration (CMC) and formed nano-sized micelles with positive surface charges in water as well as exhibiting a much lower cytotoxicity than PEI 25 kDa. Nevertheless, their gene transfection efficiency and tumor inhibition ability showed a remarkable dependence on their molecular architecture. The (AB3)3 architecture micelle copolymer exhibited the highest transfection efficiency, about 2.5 times higher than PEI. In addition, after co-delivering DOX and miR-21 inhibitor (miR-21i) into LN229 glioma cells, the micelles could mediate escaping miR-21i from lysosome degradation and the release of DOX to the nucleus, which significantly decreased the miR-21 expression. Moreover, co-delivery of DOX and miR-21i surprisingly exhibited an anti-proliferative efficiency compared with DOX or the miR-21i treatment alone. These results demonstrated that amphiphilic star-branched copolymers are highly promising for their combinatorial delivery of genes and hydrophobic therapeutants.

Keywords: Co-delivery; Polydimethylaminoethyl methacrylate; Polylactic acid; Star-branched copolymer; Synergistic effects; miR-21.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / administration & dosage*
  • Antibiotics, Antineoplastic / therapeutic use
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / pathology
  • Doxorubicin / administration & dosage*
  • Doxorubicin / therapeutic use
  • Glioma / drug therapy*
  • Glioma / pathology
  • In Situ Hybridization, Fluorescence
  • Methacrylates / administration & dosage*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • MicroRNAs / antagonists & inhibitors*
  • Microscopy, Electron, Transmission
  • Polyesters / administration & dosage*

Substances

  • Antibiotics, Antineoplastic
  • MIRN21 microRNA, human
  • Methacrylates
  • MicroRNAs
  • Polyesters
  • poly(lactide)-b-poly(N,N-dimethylamino-2-ethyl methacrylate)
  • Doxorubicin